Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Kathleen Maignan, NP, MSN, Shaked Peleg Azzam, MA, Blythe Adamson, PhD MPH, Christina M. Parrinello, PhD MPH, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 4123.

https://doi.org/10.1182/blood-2019-129470

Published: 2019

Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Neha Mehta-Shah, MD, Peter A. Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S. Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Jingxia Liu, MS, PhD, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 1550.

https://doi.org/10.1182/blood-2019-124185

Published: 2019

Journal Articles

Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients

Robert Chen, PhD, Sankeerth Garapati, David Wu, Sean Ko, Sam Falk, Djamilia Dierov, Adam Stasiw, Adomah S. Opong, ANP, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 2156.

https://doi.org/10.1182/blood-2019-129432

Published: 2019

Journal Articles

Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-Hit Lymphoma

Ian J. Hooley, BS, Christina M. Parrinello, PhD MPH, Adomah S. Opong, ANP, Kathleen Maignan, NP, MSN, Kenneth R. Carson, MD PhD, Richard I. Fisher, MD

Blood (2019) 134 (Supplement_1): 3426.

https://doi.org/10.1182/blood-2019-127062

Published: 2019

Journal Articles

Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Records (EHR)

Rebekah B. Foster, BA, Max Tromanhauser, BSE, Christopher Gayer, PhD, Patrick K. Gonzales, MS, Kathleen Maignan, NP, Adomah S. Opong, ANP, Aracelis Z. Torres, MPH, PhD, Kenneth R. Carson, MD PhD

Blood (2019) 134 (Supplement_1): 4727.

https://doi.org/10.1182/blood-2019-127181

Published: 2019

Journal Articles

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Martin W. Schoen, MDMPH, Kenneth R. Carson, MD PhD, Suhong Luo, MPH, Kristen M. Sanfilippo, MD MPHS

Blood (2019) 134 (Supplement_1): 383.

https://doi.org/10.1182/blood-2019-121807

Published: 2019

Journal Articles

Outcomes of Black Patients with Multiple Myeloma in the Veterans Health Administration

Martin W. Schoen, MDMPH, Suhong Luo, MS, Kenneth R. Carson, MD PhD, Kristen M. Sanfilippo, MD

Blood (2018) 132 (Supplement 1): 840.

https://doi.org/10.1182/blood-2018-99-119845

Published: 2018

Journal Articles

The Real-World Frequency of 24-Hour Urine Protein Electrophoresis (UPEP), Serum Free Light Chain (SFLC), and Serum Protein Electrophoresis (SPEP) Testing in Patients with Multiple Myeloma (MM)

Rebekah B. Foster, Nicole G. Lipitz, Aracelis Z. Torres, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2018-99-113508

Published: 2018

Journal Articles

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Ian J Hooley, BS, Robert Chen, PhD, Kathleen Maignan, NP, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2018-99-113636

Published: 2018

Journal Articles

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas Including AITL and DLBCL: Phase I Results

Neha Mehta-Shah, MD, Peter A Riedell, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Brad S Kahl, MD, Todd A Fehniger, MD PhD, Chaz Moreno, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 2929.

https://doi.org/10.1182/blood-2018-99-113611

Published: 2018

Journal Articles

Survival and Treatment of Black Patients with Chronic Lymphocytic Leukemia in the Veterans Health Affairs

Martin W. Schoen, MD MPH, Suhong Luo, MS, Kenneth R. Carson, MD PhD, Kristen M. Sanfilippo, MD

Blood (2018) 132 (Supplement 1): 4847.

https://doi.org/10.1182/blood-2018-99-114210

Published: 2018

Journal Articles

Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score

Kristen M. Sanfilippo, MD, Suhong Luo, MS, Tzu-Fei Wang, MD, Tanya Wildes, MD, Joseph Mikhael, MD FRCPC, MD, Jesse W. Keller, MD MPHS, Theodore S. Thomas, MD MPHS, Kenneth R. Carson, MD PhD, Brian F. Gage, MD MSc

Blood (2018) 132 (Supplement 1): 141.

https://doi.org/10.1182/blood-2018-99-116300

Published: 2018

Journal Articles

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kahee A. Mohammed, MD MPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 2174.

https://doi.org/10.1182/blood.V130.Suppl_1.2174.2174

Published: 2017

Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Positive (ALCL, ALK+): Data from 119 Patients Prospectively Registered in the International T-Cell Project

Blood (2017) 130 (Supplement 1): 4072.

https://doi.org/10.1182/blood.V130.Suppl_1.4072.4072

Published: 2017

Journal Articles

Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma

Su-Hsin Chang, PhD, Jason H. Gumbel, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kristen M. Sanfilippo, MD MPHS, Graham A Colditz, MD DrPH, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 4343.

https://doi.org/10.1182/blood.V130.Suppl_1.4343.4343

Published: 2017

Journal Articles

Aspirin May be Inadequate Thromboprophylaxis in Multiple Myeloma

Kristen M. Sanfilippo, MD, Suhong Luo, MS, Kenneth R. Carson, MD PhD, Brian F. Gage, MDMSc

Blood (2017) 130 (Supplement 1): 3419.

https://doi.org/10.1182/blood.V130.Suppl_1.3419.3419

Published: 2017

Journal Articles

The Role of Upfront Hematopoietic Stem Cell Transplantation (HSCT) in Peripheral T-Cell Lymphoma (PTCL) Patients in Complete Remission (CR) with a Special Focus on Nodal PTCL: Report from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a Prospective Multicenter Cohort Study

Blood (2017) 130 (Supplement 1): 342.

https://doi.org/10.1182/blood.V130.Suppl_1.342.342

Published: 2017

Journal Articles

Risk of Myelodysplasia and Acute Myeloid Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and Bendamustine

Martin W. Schoen, MD MPH, Kristen M. Sanfilippo, MD MPHS, Theodore S. Thomas, MD MPHS, Suhong Luo, MS, Kenneth R. Carson, MD PhD

Blood (2017) 130 (Supplement 1): 5339.

https://doi.org/10.1182/blood.V130.Suppl_1.5339.5339

Published: 2017

Journal Articles

Metformin Therapy and Survival in Multiple Myeloma Among US Veterans with Diabetes Mellitus

Jesse Keller, MD, Kristen M. Sanfilippo, MD MPHS, Suhong Luo, MPH, Brian F. Gage, MDMSc, Kenneth R Carson, MD PhD

Blood (2015) 126 (23): 4502.

https://doi.org/10.1182/blood.V126.23.4502.4502

Published: 2015

Journal Articles

Previous Agent Orange Exposure Is Correlated with Worse Outcome in Patients with Multiple Myeloma (MM)

Natalie Scott Callander, MD, Cesar O. Freytes, MD, Suhong Luo, MPH, Kenneth R Carson, MD PhD

Blood (2015) 126 (23): 4194.

https://doi.org/10.1182/blood.V126.23.4194.4194

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Cell of Origin (COO) Association with High Body Mass Index (BMI) and Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas

Machine Learning Based Predictive Model of 5-Year Survival in Multiple Myeloma Autologous Transplant Patients

Real-World Application of National Comprehensive Cancer Network (NCCN) Testing Guidelines in Diffuse Large B-Cell Lymphoma (DLBCL) Results in Underdiagnosis of Double-Hit Lymphoma

Approximating International Myeloma Working Group Uniform Response Criteria to Derive Response for Multiple Myeloma (MM) Patients Using Data from Electronic Health Records (EHR)

Outcomes in Multiple Myeloma Based on Comorbidities and Race

Outcomes of Black Patients with Multiple Myeloma in the Veterans Health Administration

The Real-World Frequency of 24-Hour Urine Protein Electrophoresis (UPEP), Serum Free Light Chain (SFLC), and Serum Protein Electrophoresis (SPEP) Testing in Patients with Multiple Myeloma (MM)

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas Including AITL and DLBCL: Phase I Results

Survival and Treatment of Black Patients with Chronic Lymphocytic Leukemia in the Veterans Health Affairs

Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score

Risk of Herpes Zoster in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine or Bendamustine

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Positive (ALCL, ALK+): Data from 119 Patients Prospectively Registered in the International T-Cell Project

Post-MGUS Diagnosis Serum M-Protein Velocity and the Risk of Progression of MGUS to Multiple Myeloma

Aspirin May be Inadequate Thromboprophylaxis in Multiple Myeloma

Risk of Myelodysplasia and Acute Myeloid Leukemia in Patients with Chronic Lymphocytic Leukemia Treated with Fludarabine and Bendamustine

Metformin Therapy and Survival in Multiple Myeloma Among US Veterans with Diabetes Mellitus

Previous Agent Orange Exposure Is Correlated with Worse Outcome in Patients with Multiple Myeloma (MM)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only